Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbiota-driven mechanisms at different stages of cancer development
Elena Ivleva, Sergei I. Grivennikov
Neoplasia (2022) Vol. 32, pp. 100829-100829
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
Despoina Chrysostomou, Lauren A. Roberts, Julian R. Marchesi, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 198-213
Open Access | Times Cited: 134
Fecal Microbiota Transplantation: Insights into Colon Carcinogenesis and Immune Regulation
Olga Brusnic, Danusia Onişor, Adrian Boicean, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6578-6578
Open Access | Times Cited: 26
Combating infections from drug-resistant bacteria: Unleashing synergistic broad-spectrum antibacterial power with high-entropy MXene/CDs
Panyong Wang, Qiannan You, Yulu Liu, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 238, pp. 113874-113874
Closed Access | Times Cited: 11
Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease Mitigation
Mary Garvey
Biomedicines (2024) Vol. 12, Iss. 4, pp. 740-740
Open Access | Times Cited: 9
Modulating gut microbiota using nanotechnology to increase anticancer efficacy of the treatments
Abduladheem Turki Jalil, Shahad N. Thabit, Zaman Kareem Hanan, et al.
Macromolecular Research (2023) Vol. 31, Iss. 8, pp. 739-752
Closed Access | Times Cited: 17
Circulating tumour cells in gastrointestinal cancers: food for thought?
Simran Asawa, Manuel Nüesch, Ana Gvozdenovic, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 11, pp. 1981-1990
Open Access | Times Cited: 11
Platelet-mimetic nano-sensor for combating postoperative recurrence and wound infection of triple-negative breast cancer
Yufei Liu, Qi Yao, Chen Chen, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 396-408
Closed Access | Times Cited: 11
The intratumor microbiome varies by geographical location and anatomical site in head and neck squamous cell carcinoma
Rishabh Yalamarty, Shruti Magesh, Daniel John, et al.
Current Problems in Cancer (2024) Vol. 50, pp. 101100-101100
Open Access | Times Cited: 4
Unveiling the Power of Gut Microbiome in Predicting Neoadjuvant Immunochemotherapy Responses in Esophageal Squamous Cell Carcinoma
Le Liu, Liping Liang, Yingxia Luo, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 4
A novel interplay between bacteria and metabolites in different early-stage lung cancer: an integrated microbiome and metabolome analysis
Xiaoqian Zhai, Dongqi Lin, Yijun Shen, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Biofilms: A cause for the development of cancer: A review
Ankit Gupta, Debasmita Bhattacharya, Sumitha Elayaperumal, et al.
The Microbe (2025), pp. 100236-100236
Open Access
Unveiling the Interplay Between the Human Microbiome and Gastric Cancer: A Review of the Complex Relationships and Therapeutic Avenues
Jenan Al‐Matouq, Hawra Al-Ghafli, Noura N. Alibrahim, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 226-226
Open Access
Human Microbiota and Metabolic Alteration in Cancer Progression and Treatment
Sarra B. Shakartalla, Tarek Elsayed, Fatimah Almsailem, et al.
(2025), pp. 411-440
Closed Access
Microbiome-mediated immune modulation in tumor microenvironment
John O. Richards, Eleanor L. Davis, L. Shakila, et al.
International review of cell and molecular biology (2025)
Closed Access
Role of human microbiota in facilitating the metastatic journey of cancer cells
Himisa Shah, Premal H. Patel, Aritro Nath, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
The Intersection of the Upper Gastrointestinal Microbiome and Oesophageal Cancer: A Review of Pathways and Therapeutic Insights
Jenny Bui, Kevin R. Ward, Rishindra M. Reddy
European Medical Journal (2025)
Open Access
Human Commensal Bacteria: Next-generation Pro- and Post-biotics for Anticancer Therapy
Himal Sapkota, Subrata Dasgupta, Bishnudeo Roy, et al.
Frontiers in Bioscience-Elite (2025) Vol. 17, Iss. 1
Open Access
The Healthcare of Tomorrow
Jagriti Ramanathan
(2025), pp. 307-361
Closed Access
The human microbiome: redefining cancer pathogenesis and therapy
Yogita K. Adlakha, Ravindresh Chhabra
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Causal associations between iron deficiency anemia and digestive system cancers: evidence from a bidirectional two-sample Mendelian randomization study
Yan Qin, Rong Zhou
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Unveiling the microbial orchestra: exploring the role of microbiota in cancer development and treatment
Esther Ugo Alum, Daniel Ejim Uti, Okechukwu Paul-Chima Ugwu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis
Eric Jou, Noé Rodríguez‐Rodríguez, Andrew N. J. McKenzie
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Exploring the human microbiome – A step forward for precision medicine in breast cancer
Asmita Jotshi, Krishna Kishore Sukla, Mohammed Monzoorul Haque, et al.
Cancer Reports (2023) Vol. 6, Iss. 11
Open Access | Times Cited: 7
Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Patients
Maria Kulecka, Paweł Czarnowski, Aneta Bałabas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8026-8026
Open Access | Times Cited: 2
Immune Checkpoint Inhibitor Therapy for Metastatic Melanoma: What Should We Focus on to Improve the Clinical Outcomes?
Sultana Mehbuba Hossain, Kevin Ly, Yih Jian Sung, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10120-10120
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top